Entity

Time filter

Source Type

Petah Tikva, Israel

Trademark
Powerid Ltd. and Power Paper Ltd. | Date: 2004-08-10

batteries; printed batteries; batteries manufactured by a printing process; smart tags and electronic tags containing programming for the processing, transmission and reception of data; smart labels and electronic labels containing programming for the processing, transmission and reception of data; smart and magnetic encoded cards containing programming for the processing, transmission and reception of data; integrated circuit cards, electronic chip cards, sensors and wireless cards, all encoded for the logging, monitoring, processing, transmission and reception of data, audio and visual information; electronic chip cards, smart cards, integrated circuit cards all encoded used in packaging, labeling, advertising, stationery and promotion purposes.


Trademark
Power Paper Ltd. | Date: 2005-05-17

medical, pharmaceutical and health care products, namely, dermatologicals; medicated skin care preparations; adhesive bandages, containing pharmaceuticals for the treatment of-- rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosis, candidiasis, onychomycosis, tinea, tinea unguium basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples, saborrheic dermatitis for transmdermal application and adhesive bandages for transdermally administering pharmaceutical preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; medical plasters impregnated with transdermally active pharmaceutical active preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; skin patches, for the transdermal delivery of pharmaceuticals, for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for application to the skin for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for medical purposes for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive skin patches for medical use for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive wound, burn and surgical dressings for application to the skin; adhesive wound, burn and surgical dressings for medical purposes; adhesive skin wound, burn and surgical dressings for medical use; wound, burn and surgical dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of dermatological disorders, leg ulcers, pressure sores, lesions, skin grafts, carcinoma and scarring; adhesive medicated dressings incorporating a pharmaceutical preparation for application to the skin for the treatment for tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; wound, burn and surgical dressings for the transdermal delivery of pharmaceuticals for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; transdermal wound, burn and surgical dressings.


Trademark
Power Paper Ltd. | Date: 2005-04-19

chemicals for use in the manufacture of batteries. batteries; printed batteries, namely, energy cells printed onto a thin polymer-based substrate; magnetically encoded smart tags and electronic tags containing programming for the processing, transmission and reception of data; magnetically encoded smart Labels and electronic labels containing programming for the processing; transmission and reception of data; integrated circuit cards, electronic chip cards, sensors and wireless cards, for the logging, monitoring, processing, transmission and reception of data, audio and visual information.


Trademark
Power Paper Ltd. | Date: 2006-06-15

batteries, electrochemical cells, single electrochemical cells, galvanic cells, single electrochemical cells/galvanic cells.


Amichai B.,Sheba Medical Center | Nitzan B.,Power Paper Ltd | Mosckovitz R.,Power Paper Ltd | Shemer A.,Sheba Medical Center
British Journal of Dermatology | Year: 2010

Background Onychomycosis is a common disease; topical treatment is usually poorly effective, while systemic treatment is more effective but may be associated with side-effects. Iontophoretic drug delivery may improve drug penetration through the nail and lead to better therapeutic results. Objectives To evaluate the efficacy, safety and tolerability of topical treatments with terbinafine HCl delivered with or without an iontophoretic patch in patients with onychomycosis of the toenails. Methods Patients enrolled into the study were divided randomly into two groups. Group A was treated with terbinafine and an iontophoretic patch (at a constant current density of 100 μA cm -2). Group B was treated with terbinafine without iontophoresis. Treatment was overnight wear, every day, 5 days per week, for 4 weeks. Follow-up period was 8 weeks from the end of treatment. Results A significant clinical response was recorded in patients of group A (active group). The percentage of patients having healthy toenail growth of more than 1·5 mm at the end of treatment was 40% compared with 11% in patients treated with terbinafine without current (passive group). The percentage of patients having fungal elements (KOH) in nail specimens decreased significantly at 8 weeks following the completion of treatment: 16% in the active group vs. 53% in the passive group. Patients in the active group reported a tingling sensation that is expected when using an iontophoretic drug delivery treatment. Conclusions The delivery of terbinafine under an electrical current of 100 μA cm-2 appears to be efficacious and safe and is well tolerated for the treatment of nail onychomycosis. © 2009 British Association of Dermatologists. Source

Discover hidden collaborations